Literature DB >> 10773951

Detection of high risk pregnancies with relation to ABO haemolytic disease of newborn.

K K Usha1, P V Sulochana.   

Abstract

IgM and IgG anti A and anti B antibody status of 100 antenatal O group mothers (who had non O group husbands) were studied. Of these, 3 mothers had an IgM anti A antibody levels ranging from 1:512 to 1:2048 and IgG ranging from 1:1204 to 1:2048, IgM anti B ranging from 1:128 to 1:512 and IgG anti B ranging from 1:256 to 1:512. All these mothers had A + ve children and all these children suffered from ABO haemolytic disease of newborn (HDN). A 4th mother had an IgM anti A titre of 1:64 and IgG anti A titre of 1:16. The titre of IgM anti B in this mother was 1:512 and that of IgG 1:1024. The child was A + ve and did not suffer from ABO haemolytic disease of newborn.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10773951     DOI: 10.1007/bf02831348

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  4 in total

1.  Neonatal jaundice due to ABO incompatibility in Sri Lankan.

Authors:  G N Lucas
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

2.  Severe ABO hemolytic disease of newborn is infrequent among Hong Kong Chinese.

Authors:  H F Wong; A Chan; C H Chui; C K Lam; C H Hui; G Cheng
Journal:  Vox Sang       Date:  1996       Impact factor: 2.144

3.  ABO hemolytic disease of the newborn is more severe in Taiwan than in white populations.

Authors:  M Lin; R E Broadberry
Journal:  Vox Sang       Date:  1995       Impact factor: 2.144

4.  A study of ABO incompatibility and neonatal jaundice in Black South African newborn infants.

Authors:  G H Vos; M Adhikari; H M Coovadia
Journal:  Transfusion       Date:  1981 Nov-Dec       Impact factor: 3.157

  4 in total
  4 in total

1.  Single versus multiple dose intravenous immunoglobulin in combination with LED phototherapy in the treatment of ABO hemolytic disease in neonates.

Authors:  Gamze Demirel; Melek Akar; Istemi Han Celik; Omer Erdeve; Nurdan Uras; Serife Suna Oguz; Ugur Dilmen
Journal:  Int J Hematol       Date:  2011-05-25       Impact factor: 2.490

Review 2.  Haemolytic disease of newborn.

Authors:  A Narang; N Jain
Journal:  Indian J Pediatr       Date:  2001-02       Impact factor: 1.967

3.  Intravenous Immunoglobulin G Treatment in ABO Hemolytic Disease of the Newborn, is it Myth or Real?

Authors:  Serdar Beken; Ibrahim Hirfanoglu; Canan Turkyilmaz; Nilgun Altuntas; Sezin Unal; Ozden Turan; Esra Onal; Ebru Ergenekon; Esin Koc; Yildiz Atalay
Journal:  Indian J Hematol Blood Transfus       Date:  2012-08-28       Impact factor: 0.900

4.  Severe ABO hemolytic disease of fetus and newborn requiring blood exchange transfusion.

Authors:  Ashish Jain; Sheetal Malhotra; Neelam Marwaha; Praveen Kumar; Ratti Ram Sharma
Journal:  Asian J Transfus Sci       Date:  2018 Jul-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.